Expression of the mast cell growth factor interleukin-3 in melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: Implications for melanoma progression

Journal of Cutaneous Pathology

Volumn 23, Issue 6, 1996, Pages 495-505

  Reed, Jon A ^a   Scott McNutt, N ^a,b   Bogdany, Jennifer K ^a   Albino, Anthony P ^c  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; INTERLEUKIN 3; INTERLEUKIN 3 RECEPTOR;

ARTICLE; CELL PROLIFERATION; CONNECTIVE TISSUE; EPIDERMIS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAST CELL; MELANOCYTE; MELANOMA; STROMA; TUMOR GROWTH; TUMOR VASCULARIZATION;

CARCINOMA IN SITU; CELL COUNT; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERLEUKIN-3; MAST CELLS; MELANOMA; NEOPLASM INVASIVENESS; NEVUS, PIGMENTED; RECEPTORS, INTERLEUKIN-3; RNA, MESSENGER; SKIN NEOPLASMS;

EID: 8044238369     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1996.tb01441.x     Document Type: Article

References (75)

1. Weinberg RA. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 1989: 49: 3713.
2. Albino AP, Fountain JW. Molecular genetics of human malignant melanoma. Cancer Treat Res 1993: 65: 201.
3. Edward M, MacKie RM. Cell-cell and cell-extracellular matrix interactions during melanoma cell invasion and metastasis. Melanoma Res 1993: 3: 227.
4. Rodeck U. Growth factor independence and growth regulatory pathways in human melanoma development. Cancer Metastasis Rev 1993: 12: 219.
5. Gattoni-Celli S, Calorini L, Simile MM, Ferrone S. Modulation by MHC class I antigens of the biology of melanoma cells. Non-immunological mechanisms. Melanoma Res 1993: 3: 285.
6. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992: 3: 65.
7. Denijn M, Ruiter DJ. The possible role of angiogenesis in the metastatic potential of human melanoma. Clinicopathological aspects. Melanoma Res 1993: 3: 5.
8. Barnhill RL, Fandrey K, Levy MA, Mihm Jr. MC, Hyman B. Angiogenesis and tumor progression of melanoma. Lab Invest 1992: 67: 331.
9. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987: 235: 442.
10. Potgens AJ, Lubsen NH, van Altena MC, Schoenmakers JG, Ruiter DJ, de Waal RM. Vascular permeability factor expression influences tumor angiogenesis in melanoma cell lines xenografted into nude mice. Am J Pathol 1995: 146: 187.
11. Schadendorf D, Moller A, Algermissen B, Worm M, Sticherling M, Czarnetzki BM. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 1993: 151: 2667.
12. Ciotti P, Rainero ML, Nicolo G, et al. Cytokine expression in human primary and metastatic melanoma cells: analysis in fresh bioptic specimens. Melanoma Res 1995: 5: 41.
13. Lu C, Kerbel RS. Interlukin-6 undergoes transition from a paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J Cell Biol 1993: 120: 1281.
14. Bennicelli JL, Guerry D 4th. Production of multiple cytokines by cultured human melanomas. Exp Dermatol 1993: 2: 186.
15. Mattei S, Colombo MP, Melani C, Sylvani A, Parmiani G, Herlyn M. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 1994: 56: 853.
16. Albino AP, Davis BM, Namis DM. Induction of growth factor RNA expression in human malignant melanoma: markers of transformation. Cancer Res 1991: 51: 4815.
17. Rodeck U, Melber K, Rath R, et al. Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J Invest Dermatol 1991: 97: 20.
18. Reed JA, McNutt NS, Albino AP. Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Implications for minor progression. Am J Pathol 1994: 144: 329.
19. Schulze Osthoff K, Risau W, Vollmer E, Sorg C. In situ detection of basic fibroblast growth factor by highly specific antibodies. Am J Pathol 1990: 137: 85.
20. Mignatti P, Rifkin DB. Release of basic fibroblast growth factor, an angiogenic factor devoid of a secretory signal sequence: a trivial phenomenon or a novel secretion mechanism? J Cell Biochem 1991: 47: 201.
21. Reed JA, Albino AP, McNutt NS. Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest 1995: 72: 215.
22. Hebda PA, Collins MA, Tharp MD. Mast cell and myofibroblast in wound healing. Dermatol Clin 1993: 11: 685.
23. Glowacki J, Mulliken JB. Mast cells in hemangiomas and vascular malformations. Pediatrics 1982: 70: 48.
24. Shea CR, Prieto VG. Mast cells in angiolipomas and hemangiomas of human skin: are they important for angiogenesis? J Cutan Pathol 1994: 21: 247.
25. Regezi JA, MacPhail LA, Daniels TE, De Souza YG, Greenspan JS, Greenspan D. Human immunodeficiency virus-associated oral Kaposi's sarcoma. A heterogeneous cell population dominated by spindle-shaped endothelial cells. Am J Pathol 1993: 143: 240.
26. Dvorak AM, Mihm Jr. MC, Osage JE, Dvorak HF. Melanoma. An ultrastructural study of the host inflammatory and vascular responses. J Invest Dermatol 1980: 75: 388.
27. Schadendorf D, Kohlmus C, Gawlik C, Suter L, Czarnetzki BM. Mast cells in melanocytic tumours. Arch Dermatol Res 1995: 287: 452.
28. Duncan LM, Richards LA, Mihm Jr. MC. Increased mast cell density in invasive melanoma. (abstract). J Cutan Pathol 1995: 22: 59.
29. Cawley EP, Hoch-Ligeti C. Association of tissue mast cells and skin tumors. Arch Dermatol 1961: 83: 146.
30. Moore RD, Stevenson J, Schoenberg MD. The response of connective tissue associated with tumors of the skin. Am J Clin Pathol 1960: 34: 125.
31. Csaba G, Acs T, Horvath C, Mold K. Genesis and function of mast cells. Mast cell and plasmacyte reaction to induced, homologous and heterologous tumours. Br J Cancer 1962: 15: 327.
32. Kessler DA, Langer RS, Pless NA, Folkman J. Mast cells and tumor angiogenesis. Int J Cancer 1976: 18: 703.
33. Roche WR. Mast cells and tumors. The specific enhancement of tumor proliferation in vitro. Am J Pathol 1985: 119: 57.
34. Roche WR. Mast cells and tumour angiogenesis: the tumour-mediated release of an endothelial growth factor from mast cells. Int J Cancer 1985: 36: 721.
35. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-α / cachectin. Nature 1990: 346: 274.
36. Norby K, Jakobsson A, Sorbo J. Quantitative angiogenesis in spreads of intact rat mesenteric windows. Microvasc Res 1990: 39: 341.
37. Duncan JI, Brown FI, McKinnon A, Long WF, Williamson FB, Thompson WD. Patterns of angiogenic response to mast cell granule constituents. Int J Microcirc Clin Exp 1992: 11: 21.
38. Galli SJ. New concepts about the mast cell. New Engl J Med 1993: 328: 257.
39. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today 1990: 11: 458.
40. Starkey JR, Crowle PK, Taubenberger S. Mast-cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis. Int J Cancer 1988: 42: 48.
41. Lopez AF, Elliott MJ, Woodcock J, Vadas MA. GM-CSF, IL-3 and IL-5: cross-competition on human hematopoietic cells. Immunol Today 1992: 13: 495.
42. Reed JA, Manahan LJ, Park C-S, Brigati DJ. Complete one-hour immunocytochemistry based on capillary action. Biotechniques 1992: 13: 434.
43. Park C-S, Brigati DJ, Manahan LJ. Automated molecular pathology: one hour in situ DNA hybridization. J Histotechnol 1991: 14: 219.
44. Reed JA, McNutt NS, Prieto VG, Albino AP. Expression of transforming growth factor-β2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression. Am J Pathol 1994: 145: 97.
45. Iezzoni JC, Kang J-H, Bucana CD, Reed JA, Brigati DJ. Rapid colorimetric detection of epidermal growth factor receptor mRNA by in situ hybridization. J Clin Lab Anal 1993: 7: 247.
46. Otsuka T, Miyajima A, Brown N, et al. Isolation and characterization of an expressible cDNA encoding human IL-3. Induction of IL-3 mRNA in human T-cell clones. J Immunol 1988: 140: 2288.
47. Pearson WR, Lipman DJ. Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 1988: 85: 2444.
48. Cowen T, Trigg P, Eady RA. Distribution of mast cells in human dermis: development of a mapping technique. Br J Dermatol 1979: 100: 635.
49. Galli SJ. New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990: 62: 5.
50. Valent P, Besemer J, Sillaber CH, et al. Failure to detect IL-3-binding sites on human mast cells. J Immunol 1990: 145: 3432.
51. Durand B, Migliaccio G, Yee NS, et al. Long-term generation of human mast cells in serum-free cultures of CD34+ cord blood cells stimulated with stem cell factor and IL-3. Blood 1994: 84: 3667.
52. Kusumi A, Kumagai K. Interleukin 3 (IL-3). Gan To Kagaku Ryoho 1994: 21: 915.
53. Ishizaka T, Saito H, Hatake K, et al. Preferential differentiation of inflammatory cells by recombinant human interleukins. Int Arch Allergy Appl Immunol 1989: 88: 46.
54. Dvorak AM, Estrella P, Kissell S, Arai N, Ishizaka T. Ultrastructure of eosinophils and basophils stimulated to develop in human cord blood mononuclear cell cultures containing recombinant human interleukin-5 or interleukin-3. Lab Invest 1989: 61: 116.
55. Dvorak AM, Furitsu T, Kissell-Rainville S, Ishizaka T. Ultrastructural identification of human mast cells resembling skin mast cells stimulated to develop in long-term human cord blood mononuclear cells cultured with 3T3 murine skin fibroblasts. J Leukocyte Biol 1992: 51: 557.
56. Fukuda T, Kakihara T, Kamishima T, et al. Leukemic cell membrane from acute myelogenous leukemias with massive mast cell infiltration has a mast cell differentiation activity under culture condition containing interleukin 3. Leuk Res 1994: 18: 749.
57. Buckley MG, Williams CM, Thompson J, et al. IL-4 enhances IL-3 and IL-8 gene expression in a human leukemic mast cell line. Immunology 1995: 84: 410.
58. Marks RM, Roche WR, Czerniecki M, Nelson DS. Mast cell granules cause proliferation of human microvascular endothelial cells. Lab Invest 1986: 55: 289.
59. Okayama Y, Semper A, Holgate ST, Church MK. Multiple cytokine mRNA expression in human mast cells stimulated via Fc epsilon RI. Int Arch Allergy Immunol 1995: 107: 158.
60. Halaban R, Kwon BS, Ghosh S, Delli Bovi P, Baird A. bFGF as an autocrine growth factor for human melanomas. Oncogene Res 1988: 3: 177.
61. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992: 258: 1798.
62. Nilsson G, Svensson V, Nilsson K. Constitutive and inducible cytokine mRNA expression in the human mast cell line HMC-1. Scand J Immunol 1995: 42: 76.
63. Craig SS, Irani A-MA, Metcalfe DD, Schwartz LB. Ultrastructural localization of heparin to human mast cells of the MCTC and MCT types by labeling with antithrombin III-gold. Lab Invest 1993: 69: 552.
64. Frater-Schroder M, Risau W, Hallmann R, Gautchi P, Bohlen P. Tumor necrosis factor type α, a potent inhibitor of endothelial growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 1987: 84: 5277.
65. Ueki N, Nakazato M, Ohkawa T, et al. Excessive production of transformig growth factor beta 1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth. Biochim Biophys Acta 1992: 1137: 189.
66. Vlodavsky I, Eldor A, Haimovitz-Friedman A, et al. Expression of heparinase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 1992: 12: 112.
67. Lees M, Taylor DJ, Wooley DE. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not gelatinases A and B. Eur J Biochem 1994: 223: 171.
68. Krejci NC, Knapp DM, Rudd RJ, Bauer EA, McGuire J. Dermal mast cell granules bind interstitial procollagenase and collagenase. J Invest Dermatol 1992: 98: 748.
69. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993: 9: 541.
70. Nilsson G, Butterfield JH, Nilsson K, Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 1994: 153: 3717.
71. Rein G, Karasek MA. Factors affecting the growth and maintenance of human skin mast cells in cell culture. Int Arch Allergy Immunol 1992: 98: 211.
72. Moore KW, O'Garra A, de Waal AR, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993: 11: 165.
73. Gruber BL, Marchese MJ, Kew RR. Transforming growth factor-beta 1 mediates mast cell chemotaxis. J Immunol 1994: 152: 5860.
74. Mattoli S, Ackerman V, Vittori E, Marini M. Mast cell chemotactic activity of RANTES. Biochem Biophys Res Commun 1995: 209: 316.
75. Taub DD, Proost P, Murphy WJ, et al. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 1995: 95: 1370.